EOM PHARMACEUTICAL HLDNGS (IMUC) Total Assets by Year
EOM PHARMACEUTICAL HLDNGS closed fiscal year 2017 with $7.0M in total assets, $2.4M in total liabilities and $4.6M in shareholder equity. This represents a decrease of 58.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2005 to 2017, and the quarters EOM PHARMACEUTICAL HLDNGS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMUC Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K | FY0810-K | FY0710-K | FY0610-K | FY0510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.0M-58.5% | $16.9M-43.9% | $30.1M+19.5% | $25.2M-13.0% | $28.9M+7.1% | $27.0M+277.9% | $7.2M+33.3% | $5.4M | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.4M-78.1% | $10.8M+28.7% | $8.4M+343.2% | $1.9M-23.5% | $2.5M-37.6% | $4.0M+0.8% | $3.9M+29.4% | $3.0M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $4.6M-24.2% | $6.1M-71.8% | $21.7M-6.7% | $23.3M-12.0% | $26.5M+14.8% | $23.1M+613.7% | $3.2M+38.4% | $2.3M+112.9% | $1.1M-62.7% | $2.9M-41.2% | $5.0M+2535.1% | $190K+836.0% | $20K |
IMUC Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'1810-Q | Q1'1810-Q | Q4'1710-Q | Q3'1710-Q | Q2'1710-Q | Q1'1710-Q | Q4'1610-K | Q3'1610-Q | Q2'1610-Q | Q1'1610-Q | Q4'1510-K | Q3'1510-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8M-20.4% | $5.2M-50.8% | $7.0M-58.5% | $6.8M-69.5% | $4.8M-75.0% | $10.5M-57.5% | $16.9M-43.9% | $22.2M-27.9% | $19.3M-41.9% | $24.7M-33.2% | $30.1M+19.5% | $30.9M+21.6% |
| Total Liabilities | $402K-94.8% | $1.5M-85.1% | $2.4M-78.1% | $7.3M-31.1% | $7.7M+4.9% | $10.0M+22.8% | $10.8M+28.7% | $10.6M+132.4% | $7.4M+98.7% | $8.2M+77.1% | $8.4M+343.2% | $4.6M+134.8% |
| Total Equity | $3.4M+216.7% | $3.7M+666.9% | $4.6M-24.2% | -$523K-104.5% | -$2.9M-124.7% | $479K-97.1% | $6.1M-71.8% | $11.6M-55.8% | $11.9M-59.6% | $16.5M-48.9% | $21.7M-6.7% | $26.3M+12.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More EOM PHARMACEUTICAL HLDNGS financials
Frequently Asked Questions
What was EOM PHARMACEUTICAL HLDNGS's total assets in fiscal year 2017?
EOM PHARMACEUTICAL HLDNGS closed fiscal year 2017 with $7.0M in total assets, $2.4M in total liabilities and $4.6M in shareholder equity.
How fast is EOM PHARMACEUTICAL HLDNGS's total assets growing?
EOM PHARMACEUTICAL HLDNGS (IMUC) total assets fell by 58.5% year over year, from $16.9M to $7.0M in fiscal year 2017.
What was EOM PHARMACEUTICAL HLDNGS's total assets in the most recent quarter?
EOM PHARMACEUTICAL HLDNGS (IMUC) reported $3.8M in total assets in Q2 2018. This represents a decrease of 20.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what EOM PHARMACEUTICAL HLDNGS (IMUC) reported on that line in every period on record.